COR Cencora, Inc. Common Stock
Cencora, Inc. Common Stock について Wikipediaからの企業概要
Cencora, Inc., formerly known as AmerisourceBergen, is an American drug wholesale and distribution company and a contract research organization, that was formed by the merger of Bergen Brunswig and AmeriSource in 2001. It was renamed to Cencora in 2023. Cencora is one of the largest pharmaceutical companies in the world and distributes generic pharmaceuticals, over-the-counter healthcare products, as well as home healthcare supplies and equipment. The company is headquartered in Conshohocken, Pennsylvania, part of the Philadelphia metropolitan area.
続きを読む
Cencora, Inc., formerly known as AmerisourceBergen, is an American drug wholesale and distribution company and a contract research organization, that was formed by the merger of Bergen Brunswig and AmeriSource in 2001. It was renamed to Cencora in 2023. Cencora is one of the largest pharmaceutical companies in the world and distributes generic pharmaceuticals, over-the-counter healthcare products, as well as home healthcare supplies and equipment. The company is headquartered in Conshohocken, Pennsylvania, part of the Philadelphia metropolitan area.
Background
AmerisourceBergen was formed in 2001 following the merger of AmeriSource Health Corporation and Bergen Brunswig Corporation. David Yost was CEO of Amerisource prior to the merger and remained in the position after the companies merged.
AmerisourceBergen has 26 pharmaceutical distribution centers in the US, nine distribution centers in Canada, four specialty distribution centers in the US, and over 1 million square feet of packaging production capacity in the US and the UK. With the addition of World Courier, the largest specialty courier company in the world, over 150 company-owned offices around the globe were added to the company.
AmerisourceBergen operates its pharmaceutical distribution business under four primary units: AmerisourceBergen Drug Corporation (ABDC), AmerisourceBergen Specialty Group (ABSG), AmerisourceBergen Consulting Services (ABCS) and World Courier. In March 2016, pharmacy Walgreens Boots Alliance Inc. announced it would exercise an option to purchase 22.7 million shares of AmerisourceBergen stock and thereby control 15% of the company.
In 2012, the firm was the largest by revenue based in Pennsylvania. The company changed its name to Cencora as of August 30, 2023 and began trading on the New York Stock Exchange under the new ticker symbol "COR". In May 2024, Cencora disclosed it had been the subject of a cyber incident in which patient information was exposed.
Products
They provide drug distribution and consulting related to medical business operations and patient services. They also distribute a line of brand name and generic pharmaceuticals, over-the-counter (OTC) health care products and home health care supplies and equipment to health care providers throughout the United States, including acute care hospitals and health systems, independent and chain retail pharmacies, mail-order facilities, physicians, clinics and other alternate site facilities, as well as nursing and assisted living centers. They also provide pharmaceuticals and pharmacy services to long-term care, workers' compensation and specialty drug patients.
AmerisourceBergen handles about 20% of all of the pharmaceuticals sold and distributed throughout the United States and ranked 10th on the Fortune 500 list for 2020 with over $179 billion in annual revenue.
Good Neighbor Pharmacy
Good Neighbor Pharmacy is an American retailers' cooperative network of more than 3,400 independently owned and operated pharmacies. It has a business affiliation with AmerisourceBergen, which sponsors the network and owns the name "Good Neighbor Pharmacy." Good Neighbor Pharmacy is the sponsor for "ThoughtSpot," the annual trade show held in both Orlando and Las Vegas.
Acquisition history
In 2011, the company acquired IntrinsiQ for $35 million and Premier Source for an undisclosed amount. In July, Steven Collis replaced Yost as CEO of the company.
In March 2012, AmerisourceBergen agreed to acquire World Courier Group Inc, a transportation and logistics provider for the biopharmaceutical industry, for $520 million.
In January 2015, the company bought MWI Veterinary for $2.5 billion. In October, they agreed to buy PharMEDium, a compounding drug company, for $2.58 billion.
On January 3, 2018, AmerisourceBergen acquired H. D. Smith, the largest privately held national pharmaceutical wholesaler in the U.S.
On June 2, 2021, AmerisourceBergen acquired Alliance Healthcare from Walgreens Boots Alliance for approximately $6.5 billion, made up of $6.275 billion in cash and 2 million shares of AmerisourceBergen common stock.
On January 2, 2025, Cencora acquired 85% of Retina Consultants of America for approximately $4.4 billion.
Distribution of Remdesivir
In June 2020, the U.S. Department of Health and Human Services (HHS) announced an unusual agreement for the distribution of remdesivir, the first coronavirus drug. HHS agreed to manufacturer Gilead's wholesale acquisition price, while HHS would continue to work together with state governments and AmerisourceBergen to allocate shipments of remdesivir vials to American hospitals through the end of September 2020, and in exchange, during that time-frame American patients would be allocated over 90% of Gilead's projected remdesivir output of more than 500,000 treatment courses.
Finances
For the fiscal year 2019, AmerisourceBergen reported earnings of US$1.11 billion, with an annual revenue of US$179.58 billion. AmerisourceBergen's shares traded at over $88 per share, and its market capitalization was valued at over US$19.2 billion in September 2019.
Controversies
Opioid epidemic
AmerisourceBergen is among several distributors that have been sued by West Virginia for contributing to the opioid epidemic in the United States, by shipping inordinate amounts of pain medication into the state.
In December 2019, Michigan became the first state to sue AmerisourceBergen and three other opioid distributors as drug dealers for their role in the state's opioid crisis. The lawsuit is filed under the Michigan Drug Dealer Liability Act. AmerisourceBergen was among four companies who, because of their role in the addiction crisis, agreed to pay $260 million to two Ohio counties. In May 2020, Oklahoma Attorney General Mike Hunter sued AmerisourceBergen in Bryan County District Court, Oklahoma. The lawsuit alleged that the company's actions helped fuel Oklahoma's opioid crisis. The suit was filed along with lawsuits against Cardinal Health and McKesson, and the three lawsuits allege that the three companies provided "enough opioids to Bryan County that every adult resident there could have had 144 hydrocodone tablets." In January 2022, AmerisourceBergen, McKesson, Cardinal Health, and Johnson & Johnson agreed to pay $26 billion to settle with all but five of the states suing them. The deal covered the bulk of the grievances against these four companies, including 90 percent of municipal governments, 46 states, and Washington, DC. Had the states gone to court, the companies could have faced up to $95 billion in penalties. AmerisourceBergen and the three other companies did not admit wrongdoing.
Legal issues
In October 2018, AmerisourceBergen agreed to pay $625 million to settle civil fraud allegations resulting from its repackaging and sale of adulterated drugs and unapproved new drugs, double billing and providing kickbacks to physicians. The company had previously been found guilty of a misdemeanor charge related to the repackaging and distribution of pre-filled syringes that lacked FDA approval. In connection with this case, AmerisourceBergen agreed to pay $260 million, bringing the total settlement amount to $885 million.
As part of the civil settlement, ABC admitted that between January 2001 and January 2014, MII and OSC operated a program that created, packed and shipped millions of pre-filled syringes (PFS) to oncology practices for administration to vulnerable cancer patients (the PFS Program). At MII, an ABC subsidiary located in Alabama, the drug product was removed from the original glass vials and multiple vials of the product were pooled in untested plastic containers. Then the drug, including the overfill, was extracted and repackaged into syringes. By harvesting the overfill, ABC was able to create more doses than it bought from the original vial manufacturers and avoid opening some of the vials. ABC retained the unopened vials and sold them to other customers and to its subsidiary ABDC for resale. During the 13 years the PFS Program was in operation, MII manufactured thousands of syringes daily, and eventually over one million syringes per year. These syringes were sold throughout the United States. Approximately 57% of the patients who were injected with the PFS were Federal Health Care Program beneficiaries. The profit from the PFS Program was between $2.3 and $14.4 million annually for a total profit of at least $99.6 million.
ABC’s scheme enabled it to bill multiple health care providers for the same vial of drug, causing some of those providers to bill the Federal Health Care Programs for the same vial more than once. The scheme also enabled ABC to increase its market share by offering various product discounts, which it leveraged to obtain new customers and to keep existing customers who purchased its entire portfolio of oncology drugs. ABC excluded the entire PFS Program from its standard regulatory audit and pedigree compliance programs. AmerisourceBergen's stock price reportedly plummeted after they were among other drug distributors who offered $10 billion to settle their portion of the national opioids lawsuit. States countered with $45 billion.
In 2022, the United States government filed a lawsuit against AmerisourceBergen for contributing to the opioid crisis in America. The suit, which was filed by the United States Department of Justice with federal prosecutors in New Jersey, Colorado, Pennsylvania, and New York, alleged that the company distributed opioids that were later resold illegally.
出典: Wikipedia (英語), CC BY-SA 4.0 · Wikipediaで表示 ↗
COR 株価スナップショット 価格、時価総額、P/E、EPS、ROE、負債/資本、52週レンジ
COR 株価チャート 技術指標付きの日次 OHLCV — パン、ズーム、ビューのカスタマイズ
10年間のパフォーマンス 収益、純利益、利益率、EPSのトレンド
バリュエーション P/E、P/S、P/B、EV/EBITDA比率 — 株は割高か割安か？
収益性 粗利益率、営業利益率、純利益率、ROE、ROA、ROIC
財務健全性 負債、流動性、支払能力 — バランスシートの健全性
成長 収益、EPS、純利益の成長率：前年比、3年CAGR、5年CAGR
資本効率 総資産回転率、棚卸資産回転率、売掛金回転率
配当金 利回り、配当性向、配当履歴、5年CAGR
| 権利落ち日 | 金額 |
|---|---|
| 2026年5月15日 | $0.6000 |
| 2026年2月13日 | $0.6000 |
| 2025年11月14日 | $0.6000 |
| 2025年8月15日 | $0.5500 |
| 2025年5月16日 | $0.5500 |
| 2025年2月14日 | $0.5500 |
| 2024年11月15日 | $0.5500 |
| 2024年8月9日 | $0.5100 |
| 2024年5月9日 | $0.5100 |
| 2024年2月8日 | $0.5100 |
| 2023年11月10日 | $0.5100 |
| 2023年8月10日 | $0.4850 |
| 2023年5月11日 | $0.4850 |
| 2023年2月9日 | $0.4850 |
| 2022年11月10日 | $0.4850 |
| 2022年8月12日 | $0.4600 |
| 2022年5月13日 | $0.4600 |
| 2022年2月11日 | $0.4600 |
| 2021年12月1日 | $1.2700 |
| 2021年11月12日 | $0.4600 |
COR アナリストコンセンサス 強気・弱気のアナリストの見解、12ヶ月の目標株価、アップサイド
- 強い買い 5 25.0%
- 買い 10 50.0%
- 保有 5 25.0%
- 売り 0 0.0%
- 強い売り 0 0.0%
12ヶ月目標株価
12 アナリスト · 2026-08-13決算履歴 EPS実績 vs 予想、サプライズ%、達成率、次回決算日
| 期間 | EPS Actual | EPS 予想 | サプライズ |
|---|---|---|---|
| 2026年9月30日 | $4.48 | $4.39 | 0.09% |
| 2026年6月30日 | $4.48 | $4.39 | 0.09% |
| 2026年3月31日 | $4.75 | $4.86 | -0.11% |
| 2025年12月31日 | $4.08 | $4.08 | 0.00% |
| 2025年9月30日 | $3.84 | $3.82 | 0.02% |
| 2025年6月30日 | $4.00 | $3.88 | 0.12% |
| 2025年3月31日 | $4.42 | $4.15 | 0.27% |
同業他社比較（GICSサブインダストリー） 主要メトリクスとセクターピアの比較
| ティッカー | 時価総額 | P/E | 売上高 YoY | 純利益率 | ROE | 粗利益率 |
|---|---|---|---|---|---|---|
| COR | $60.61B | 39.3 | 9.3% | 0.48% | 144.3% | 3.6% |
| MCK | $242.30B | 22.5 | 12.4% | 1.2% | -224.3% | 3.6% |
| CAH | — | 32.9 | 14.2% | 0.67% | -60.5% | 3.8% |
| HSIC | $8.81B | 23.3 | 4.0% | 3.0% | 12.0% | 31.1% |
| AHCO | $1.35B | -19.2 | -0.49% | -2.2% | -4.6% | — |
| ACH | — | — | — | — | — | — |
| MEDS | — | — | — | — | — | — |
完全なファンダメンタルズ 年次別全指標 — 損益計算書、貸借対照表、キャッシュフロー
損益計算書 15
| 指標 | トレンド | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $321.33B | $293.96B | $262.17B | $238.59B | $213.99B | $189.89B | $179.59B | $167.94B | $153.14B | $146.85B | $135.96B | $119.57B | |
| Cost of Revenue | $309.85B | $284.05B | $253.21B | $230.29B | $207.05B | $184.70B | $174.45B | $163.33B | $148.60B | $142.58B | $132.43B | $116.59B | |
| Gross Profit | $11.48B | $9.91B | $8.96B | $8.30B | $6.94B | $5.19B | $5.14B | $4.61B | $4.55B | $4.27B | $3.53B | $2.98B | |
| SG&A Expense | $6.49B | $5.66B | $5.31B | $4.85B | $3.59B | $2.77B | $2.66B | $2.46B | $2.13B | $2.09B | $1.91B | $1.58B | |
| Operating Expenses | $6.99B | $6.09B | $5.72B | · | · | · | · | · | · | · | · | · | |
| Operating Income | $2.63B | $2.18B | $2.34B | $2.37B | $2.35B | $-5.14B | $1.11B | $1.44B | $1.06B | $1.53B | $422M | $782M | |
| Other Non-op | $-79M | $-14M | $49M | $27M | $42M | $2M | $13M | $-25M | $3M | $5M | $-14M | $4M | |
| Pretax Income | $2.26B | $2.00B | $2.16B | $2.18B | $2.22B | $-5.29B | $967M | $1.18B | $918M | $1.39B | $269M | $670M | |
| Income Tax | $691M | $485M | $428M | $517M | $677M | $-1.89B | $113M | $-438M | $553M | $-37M | $407M | $388M | |
| Net Income | $1.55B | $1.51B | $1.75B | $1.70B | $1.54B | $-3.41B | $855M | $1.66B | $364M | $1.43B | $-138M | $274M | |
| EPS (Basic) | $8.02 | $7.60 | $8.62 | $8.15 | $7.48 | $-16.65 | $4.07 | $7.61 | $1.67 | $6.73 | $-0.63 | $1.21 | |
| EPS (Diluted) | $7.96 | $7.53 | $8.53 | $8.04 | $7.39 | $-16.65 | $4.04 | $7.53 | $1.64 | $6.32 | $-0.63 | $1.16 | |
| Shares (Basic) | 193,820,000 | 198,503,000 | 202,511,000 | 208,472,000 | 205,919,000 | 204,783,000 | 210,165,000 | 217,872,000 | 218,375,000 | 212,206,000 | 217,786,000 | 227,367,000 | |
| Shares (Diluted) | 195,214,000 | 200,284,000 | 204,591,000 | 211,210,000 | 208,465,000 | 204,783,000 | 211,840,000 | 220,336,000 | 221,602,000 | 225,959,000 | 217,786,000 | 235,405,000 | |
| EBITDA | $3.68B | $3.27B | $3.30B | $3.06B | $2.86B | $-4.74B | $1.57B | $1.91B | $1.46B | $1.89B | $661M | $964M |
貸借対照表 29
| 指標 | トレンド | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $4.36B | $3.13B | $2.59B | $3.39B | $2.55B | $4.60B | $3.37B | $2.49B | $2.44B | $2.74B | $2.17B | $1.81B | |
| Receivables | $25.23B | $23.87B | $20.91B | $18.45B | $18.17B | $13.85B | $12.39B | $11.31B | $10.30B | $9.18B | $8.22B | $6.31B | |
| Inventory | $20.49B | $19.00B | $17.45B | $15.56B | $15.37B | $12.59B | $11.06B | $11.92B | $11.46B | $10.72B | $9.76B | $8.59B | |
| Prepaid Expense | $539M | $539M | $449M | $488M | $854M | $189M | $157M | $169M | $103M | $210M | $189M | $85M | |
| Other Current Assets | · | · | · | · | · | · | · | · | · | · | · | $85M | |
| Current Assets | $52.24B | $47.72B | $42.80B | $39.59B | $38.80B | $33.06B | $28.13B | $25.89B | $24.30B | $22.85B | $20.33B | $16.80B | |
| PP&E (Net) | $2.54B | $2.18B | $2.14B | $2.14B | $2.16B | $1.48B | $1.77B | $1.89B | $1.80B | $1.53B | $1.19B | $900M | |
| PP&E (Gross) | $5.73B | $5.22B | $4.74B | $4.39B | $4.08B | $3.24B | $3.35B | $3.41B | $3.09B | $2.62B | $2.14B | $1.69B | |
| Accum. Depreciation | $3.19B | $3.03B | $2.60B | $2.25B | $1.92B | $1.76B | $1.58B | $1.52B | $1.29B | $1.09B | $950M | $793M | |
| Goodwill | $13.68B | $9.32B | $9.57B | $8.50B | $9.03B | $6.71B | $6.71B | $6.66B | $6.04B | $5.99B | $4.14B | $2.95B | |
| Intangibles | $3.77B | $4.00B | $4.43B | $4.33B | $5.26B | $1.89B | $2.29B | $2.95B | $2.83B | $2.97B | $1.99B | $533M | |
| Other Non-current Assets | $4.15B | $3.64B | $3.42B | $1.76B | $1.79B | $780M | $269M | $271M | $338M | $296M | $298M | $351M | |
| Total Assets | $76.59B | $67.10B | $62.56B | $56.56B | $57.34B | $44.27B | $39.17B | $37.67B | $35.32B | $33.64B | $27.96B | $21.53B | |
| Accounts Payable | $54.72B | $50.94B | $45.84B | $40.19B | $38.01B | $31.71B | $28.39B | $26.84B | $25.40B | $23.93B | $20.89B | $15.59B | |
| Accrued Liabilities | $2.98B | $2.76B | $2.35B | $2.21B | $2.86B | $1.65B | $1.06B | $881M | $1.40B | $744M | $692M | $562M | |
| Short-term Debt | · | · | · | · | · | · | · | · | · | · | $0 | · | |
| Current Liabilities | $57.82B | $54.28B | $48.83B | $43.48B | $41.36B | $33.85B | $29.58B | $27.87B | $26.82B | $25.28B | $21.58B | $17.25B | |
| Capital Leases | $1.42B | $1.03B | $924M | $864M | $946M | $386M | $321M | $352M | $352M | $276M | $246M | · | |
| Deferred Tax | $1.62B | $1.64B | $1.66B | $1.62B | $1.69B | $686M | $1.86B | $1.83B | $2.49B | $2.21B | $1.94B | $241M | |
| Other Non-current Liabilities | $3.64B | $1.99B | $1.88B | $977M | $1.08B | $473M | $99M | $110M | $75M | $160M | $85M | $88M | |
| Long-term Debt | $7.66B | $4.39B | $4.79B | $5.70B | $6.68B | $4.12B | $4.17B | $177M | $3.44B | $4.19B | $3.49B | $2.00B | |
| Total Debt | $7.54B | $3.81B | $4.15B | $4.63B | $6.38B | $3.62B | $4.03B | $4.17B | $3.43B | $3.59B | $3.49B | $2.00B | |
| Common Stock | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | |
| Retained Earnings | $6.53B | $5.42B | $4.32B | $2.98B | $1.67B | $518M | $4.24B | $3.72B | $2.40B | $2.30B | $1.16B | $1.57B | |
| Treasury Stock | $10.33B | $9.82B | $8.25B | $7.02B | $6.47B | $6.51B | $6.10B | $5.43B | $4.76B | $4.40B | $4.15B | $2.31B | |
| AOCI | $-901M | $-989M | $-1.40B | $-1.83B | $-445M | $-109M | $-112M | $-79M | $-96M | $-114M | $-136M | $-52M | |
| Stockholders' Equity | $1.51B | $646M | $522M | $-212M | $223M | $-1.02B | $2.88B | $2.93B | $2.06B | $2.13B | $616M | $1.94B | |
| Liabilities + Equity | $76.59B | $67.10B | $62.56B | $56.56B | $57.34B | $44.27B | $39.17B | $37.67B | $35.32B | $33.64B | $27.96B | $21.53B | |
| Shares Outstanding | 193,937,673 | 194,943,968 | 200,814,804 | 206,203,817 | 208,089,298 | 204,226,465 | 206,760,654 | 213,217,882 | 217,993,598 | 220,050,502 | 206,891,873 | 221,908,650 |
キャッシュフロー 19
| 指標 | トレンド | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $1.05B | $1.09B | $964M | $694M | $505M | $391M | $462M | $465M | $398M | $365M | $249M | $189M | |
| Stock-based Comp | $148M | $148M | $125M | $93M | $100M | $74M | $59M | $62M | $62M | $65M | $61M | $43M | |
| Deferred Tax | $60M | $-102M | $-119M | $196M | $335M | $-1.54B | $29M | $-796M | $319M | $-131M | $21M | $38M | |
| Amort. of Intangibles | $557M | $663M | $554M | $307M | $178M | $111M | $167M | $181M | $161M | $152M | $56M | $26M | |
| Restructuring | $229M | $234M | $230M | $63M | $82M | $6.81B | $330M | $184M | $959M | $103M | $38M | $8M | |
| Other Non-cash | $1.06B | $838M | $1.20B | $21M | $187M | $6.70B | $939M | $21M | $361M | $1.45B | $3.73B | $919M | |
| Operating Cash Flow | $3.88B | $3.48B | $3.91B | $2.70B | $2.67B | $2.21B | $2.34B | $1.41B | $1.50B | $3.18B | $3.92B | $1.46B | |
| CapEx | $668M | $487M | $458M | $496M | $438M | $370M | $310M | $336M | $466M | $465M | $232M | $264M | |
| Investing Cash Flow | $-4.98B | $-618M | $-2.60B | $-368M | $-6.14B | $-380M | $-376M | $-1.11B | $-498M | $-3.17B | $-2.93B | $-384M | |
| Debt Issued | · | · | · | · | · | · | · | · | · | · | · | $1.10B | |
| Net Debt Issued | $-1.28B | · | · | · | $-835M | $-598M | $-511M | $-681M | $-750M | $-800M | $-500M | $566M | |
| Stock Issued | · | · | · | $0 | $0 | $66M | $0 | $0 | · | · | · | · | |
| Stock Repurchased | $435M | $1.49B | $1.18B | $484M | $82M | $420M | $674M | $639M | $330M | $2.27B | $1.86B | $754M | |
| Net Stock Activity | $-435M | $-1.49B | $-1.18B | $-484M | $-82M | $-354M | $-674M | $-639M | $-330M | $-2.27B | $-1.86B | $-754M | |
| Dividends Paid | $437M | $416M | $399M | $392M | $367M | $344M | $339M | $333M | $320M | $288M | $254M | $214M | |
| Financing Cash Flow | $2.25B | $-2.33B | $-2.22B | $-1.75B | $1.95B | $-604M | $-1.09B | $-243M | $-1.31B | $565M | $-632M | $-503M | |
| Net Change in Cash | $1.10B | $545M | $-841M | $523M | $-1.53B | $1.22B | $882M | $57M | $-307M | $574M | $359M | $578M | |
| Taxes Paid | $571M | $604M | $463M | $244M | $94M | $139M | $118M | $104M | $105M | $18M | $300M | $197M | |
| Free Cash Flow | $3.21B | $3.00B | $3.45B | $2.21B | $2.23B | $1.84B | $2.03B | $1.07B | $1.04B | $2.71B | $3.69B | $1.20B |
収益性 8
| 指標 | トレンド | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 3.6% | 3.4% | 3.4% | 3.5% | 3.2% | 2.7% | 2.9% | 2.8% | 3.0% | 2.9% | 2.6% | 2.5% | |
| Operating Margin | 0.82% | 0.74% | 0.89% | 0.99% | 1.1% | -2.7% | 0.62% | 0.86% | 0.69% | 1.0% | 0.31% | 0.65% | |
| Net Margin | 0.48% | 0.51% | 0.67% | 0.71% | 0.72% | -1.8% | 0.48% | 0.99% | 0.24% | 0.97% | -0.10% | 0.23% | |
| Pretax Margin | 0.70% | 0.68% | 0.82% | 0.91% | 1.0% | -2.8% | 0.54% | 0.70% | 0.60% | 0.95% | 0.20% | 0.56% | |
| EBITDA Margin | 1.1% | 1.1% | 1.3% | 1.3% | 1.3% | -2.5% | 0.88% | 1.1% | 0.95% | 1.3% | 0.49% | 0.81% | |
| ROA | 2.2% | 2.3% | 2.9% | 3.0% | 3.0% | -8.2% | 2.2% | 4.5% | 1.1% | 4.6% | -0.55% | 1.4% | |
| ROE | 144.3% | 258.4% | 1124.4% | 28805.8% | -387.1% | -366.5% | 29.4% | 66.4% | 17.4% | 104.0% | -10.5% | 13.0% | |
| ROIC | 20.2% | 37.0% | 40.2% | 40.9% | 24.8% | -126.9% | 14.2% | 27.9% | 7.7% | 27.4% | -5.0% | 8.3% |
流動性と支払能力 4
| 指標 | トレンド | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 0.9 | 0.9 | 0.9 | 0.9 | 0.9 | 1.0 | 1.0 | 0.9 | 0.9 | 0.9 | 0.9 | 1.0 | |
| Quick Ratio | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | |
| Debt / Equity | 5.0 | 5.9 | 7.9 | -21.9 | 28.6 | -3.6 | 1.4 | 1.4 | 1.7 | 1.7 | 5.5 | 1.0 | |
| LT Debt / Equity | 5.0 | 5.9 | 7.9 | -21.9 | 28.6 | -3.6 | 1.4 | 1.4 | 1.7 | 1.7 | 5.5 | 1.0 |
効率性 3
| 指標 | トレンド | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 4.5 | 4.5 | 4.4 | 4.2 | 4.2 | 4.6 | 4.7 | 4.6 | 4.4 | 4.8 | 5.5 | 5.9 | |
| Inventory Turnover | 15.7 | 15.6 | 15.3 | 14.9 | 14.8 | 15.6 | 15.2 | 14.0 | 13.4 | 13.9 | 14.4 | 15.0 | |
| Receivables Turnover | 13.1 | 13.1 | 13.3 | 13.0 | 13.4 | 14.5 | 15.2 | 15.5 | 15.7 | 16.9 | 18.7 | 19.3 |
成長率 8
| 指標 | トレンド | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 9.3% | 12.1% | 9.9% | 11.5% | 12.7% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 10.4% | 11.2% | 11.3% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 11.1% | · | · | · | · | · | · | · | · | · | · | · | |
| EPS YoY | 5.7% | -11.7% | 6.1% | 8.8% | · | · | · | · | · | · | · | · | |
| EPS CAGR 3Y | -0.33% | 0.63% | · | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | 3.0% | -13.5% | 2.7% | 10.3% | · | · | · | · | · | · | · | · | |
| Net Income CAGR 3Y | -2.9% | -0.67% | · | · | · | · | · | · | · | · | · | · | |
| Dividend CAGR 5Y | 4.9% | · | · | · | · | · | · | · | · | · | · | · |
バリュエーション（TTM） 16
| 指標 | トレンド | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $321.33B | $293.96B | $262.17B | $238.59B | $213.99B | $189.89B | $179.59B | $167.94B | $153.14B | $146.85B | $135.96B | $119.57B | |
| Net Income TTM | $1.55B | $1.51B | $1.75B | $1.70B | $1.54B | $-3.41B | $855M | $1.66B | $364M | $1.43B | $-138M | $274M | |
| Market Cap | $60.61B | $43.88B | $36.14B | $27.91B | $24.86B | $19.79B | $17.02B | $19.66B | $18.04B | $17.78B | $19.65B | $17.15B | |
| Enterprise Value | $63.80B | $44.56B | $37.69B | $29.15B | $28.69B | $18.81B | $17.68B | $21.34B | $19.03B | $18.63B | $20.98B | $17.34B | |
| P/E | 39.3 | 29.9 | 21.1 | 16.8 | 16.2 | -5.8 | 20.4 | 12.2 | 50.5 | 12.8 | -150.8 | 66.6 | |
| P/S | 0.2 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | |
| P/B | 40.2 | 67.9 | 69.2 | -131.9 | 111.3 | -19.4 | 5.9 | 6.7 | 8.7 | 8.3 | 31.0 | 8.8 | |
| P / Cash Flow | 15.6 | 12.6 | 9.2 | 10.3 | 9.3 | 9.0 | 7.3 | 13.9 | 12.0 | 5.6 | 5.0 | 11.7 | |
| P / FCF | 18.9 | 14.6 | 10.5 | 12.6 | 11.2 | 10.8 | 8.4 | 18.3 | 17.4 | 6.5 | 5.3 | 14.3 | |
| EV / EBITDA | 17.3 | 13.6 | 11.4 | 9.5 | 10.0 | -4.0 | 11.2 | 11.2 | 13.1 | 9.9 | 31.8 | 18.0 | |
| EV / FCF | 19.9 | 14.9 | 10.9 | 13.2 | 12.9 | 10.2 | 8.7 | 19.9 | 18.3 | 6.9 | 5.7 | 14.5 | |
| EV / Revenue | 0.2 | 0.2 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.2 | 0.1 | |
| Dividend Yield | 0.72% | 0.95% | 1.1% | 1.4% | 1.5% | 1.7% | 2.0% | 1.7% | 1.8% | 1.6% | 1.3% | 1.2% | |
| Earnings Yield | 2.5% | 3.4% | 4.7% | 5.9% | 6.2% | -17.2% | 4.9% | 8.2% | 2.0% | 7.8% | -0.66% | 1.5% | |
| Payout Ratio | 28.1% | 27.6% | 22.9% | 23.1% | 23.8% | -10.1% | 39.6% | 20.1% | 87.9% | 20.2% | -188.2% | 77.6% | |
| Annual Payout | $437M | $416M | $399M | $392M | $367M | $344M | $339M | $333M | $320M | $288M | $254M | $214M |
損益計算書 15
| 指標 | トレンド | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $84.75B | $78.36B | $85.93B | $83.73B | $80.66B | $75.45B | $81.49B | $79.05B | $74.24B | $68.41B | $72.25B | $68.92B | $66.95B | $63.46B | $62.85B | $61.17B | |
| Cost of Revenue | $81.15B | $74.77B | $82.86B | $80.77B | $77.76B | $72.39B | $78.93B | $76.56B | $71.83B | $65.88B | $69.78B | $66.67B | $64.68B | $61.16B | $60.70B | $59.19B | |
| Gross Profit | $3.61B | $3.59B | $3.07B | $2.95B | $2.91B | $3.06B | $2.56B | $2.49B | $2.41B | $2.54B | $2.47B | $2.25B | $2.26B | $2.30B | $2.15B | $1.99B | |
| SG&A Expense | $2.13B | $1.98B | $1.80B | $1.75B | $1.67B | $1.60B | $1.47B | $1.49B | $1.38B | $1.39B | $1.40B | $1.39B | $1.30B | $1.32B | $1.29B | $1.26B | |
| Operating Expenses | $2.28B | $2.11B | $1.93B | $1.88B | $1.80B | $1.72B | $1.59B | · | · | · | · | · | · | · | · | · | |
| Operating Income | $1.12B | $1.14B | $760M | $19M | $868M | $1.04B | $706M | $127M | $672M | $553M | $823M | $477M | $670M | $561M | $633M | $455M | |
| Other Non-op | $17M | $1.09B | $21M | $-128M | $110M | $-4M | $-58M | $20M | $-13M | $-22M | $1M | $30M | $-3M | $16M | $6M | $-21M | |
| Pretax Income | $996M | $2.09B | $709M | $-187M | $896M | $929M | $620M | $125M | $628M | $467M | $783M | $446M | $609M | $512M | $593M | $382M | |
| Income Tax | $220M | $459M | $143M | $146M | $207M | $211M | $127M | $118M | $141M | $46M | $180M | $97M | $130M | $84M | $117M | $84M | |
| Net Income | $764M | $1.64B | $560M | $-340M | $687M | $718M | $489M | $3M | $483M | $421M | $602M | $351M | $480M | $435M | $480M | $295M | |
| EPS (Basic) | $3.95 | $8.44 | $2.88 | $-1.75 | $3.55 | $3.70 | $2.52 | $0.04 | $2.44 | $2.11 | $3.01 | $1.75 | $2.37 | $2.15 | $2.35 | $1.43 | |
| EPS (Diluted) | $3.94 | $8.40 | $2.87 | $-1.74 | $3.52 | $3.68 | $2.50 | $0.04 | $2.42 | $2.09 | $2.98 | $1.72 | $2.35 | $2.13 | $2.33 | $1.40 | |
| Shares (Basic) | 193,147,000 | 194,545,000 | 194,219,000 | -387,556,000 | 193,822,000 | 193,796,000 | 193,758,000 | -399,244,000 | 198,260,000 | 199,406,000 | 200,081,000 | -406,186,000 | 202,349,000 | 202,316,000 | 204,032,000 | -418,212,000 | |
| Shares (Diluted) | 193,944,000 | 195,383,000 | 195,319,000 | -390,298,000 | 195,230,000 | 195,094,000 | 195,188,000 | -402,777,000 | 200,047,000 | 201,177,000 | 201,837,000 | -410,367,000 | 204,375,000 | 204,256,000 | 206,327,000 | -423,687,000 | |
| EBITDA | $1.39B | $1.39B | $1.02B | · | $868M | $1.04B | $706M | · | $672M | $553M | $823M | · | $670M | $561M | $633M | · |
貸借対照表 27
| 指標 | トレンド | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $2.82B | $2.18B | $1.75B | $4.36B | $2.23B | $1.98B | $3.22B | $3.13B | $3.31B | $2.07B | $2.87B | $2.59B | $1.39B | $1.54B | $1.69B | $3.39B | |
| Receivables | $25.45B | $24.89B | $25.98B | $25.23B | $24.56B | $23.72B | $24.55B | $23.87B | $24.05B | $22.64B | $21.58B | · | $20.80B | $19.49B | $18.63B | · | |
| Inventory | $21.03B | $20.01B | $24.08B | $20.49B | $20.14B | $18.97B | $20.51B | $19.00B | $18.30B | $17.63B | $18.65B | · | $16.85B | $16.96B | $16.78B | · | |
| Prepaid Expense | $636M | $637M | $678M | $539M | $451M | $575M | $516M | $539M | $460M | $512M | $493M | · | $493M | $488M | $1.99B | · | |
| Current Assets | $55.34B | $53.14B | $54.15B | $52.24B | $48.81B | $46.53B | $49.99B | $47.72B | $47.31B | $44.16B | $44.86B | · | $40.99B | $39.99B | $40.71B | · | |
| PP&E (Net) | $2.84B | $2.81B | $2.45B | $2.54B | $2.43B | $2.30B | $2.10B | $2.18B | $2.08B | $2.09B | $2.12B | · | $2.15B | $2.15B | $2.14B | · | |
| PP&E (Gross) | · | · | · | $5.73B | · | · | · | $5.22B | · | · | · | · | · | · | · | · | |
| Accum. Depreciation | · | · | · | $3.19B | · | · | · | $3.03B | · | · | · | · | · | · | · | · | |
| Goodwill | $16.52B | $16.45B | $13.73B | $13.68B | $14.33B | $14.09B | $9.18B | $9.32B | $9.61B | $9.62B | $9.66B | $9.57B | $9.66B | $9.63B | $8.60B | $8.50B | |
| Intangibles | $5.93B | $6.05B | $3.68B | $3.77B | $3.93B | $3.86B | $3.68B | $4.00B | $4.01B | $4.18B | $4.38B | · | $4.77B | $4.88B | $4.43B | · | |
| Other Non-current Assets | $3.01B | $3.01B | $4.14B | $4.15B | $4.23B | $4.17B | $3.89B | $3.64B | $3.53B | $3.57B | $3.46B | · | $3.40B | $1.88B | $1.80B | · | |
| Total Assets | $83.81B | $81.65B | $78.36B | $76.59B | $73.96B | $71.19B | $69.05B | $67.10B | $66.77B | $63.87B | $64.69B | · | $61.18B | $58.77B | $57.91B | · | |
| Accounts Payable | $54.70B | $51.88B | $56.06B | $54.72B | $51.04B | $50.11B | $49.91B | $50.94B | $49.88B | $46.32B | $47.74B | · | $43.75B | $42.73B | $41.76B | · | |
| Accrued Liabilities | $3.35B | $3.20B | $2.73B | $2.98B | $2.72B | $2.45B | $2.39B | $2.76B | $2.53B | $2.37B | $2.44B | · | $2.17B | $2.07B | $2.01B | · | |
| Current Liabilities | $59.20B | $56.13B | $59.13B | $57.82B | $53.96B | $53.33B | $54.51B | $54.28B | $52.97B | $49.76B | $50.77B | · | $46.78B | $45.07B | $44.76B | · | |
| Capital Leases | · | · | · | $1.42B | · | · | · | $1.03B | · | · | · | · | · | · | · | · | |
| Deferred Tax | $1.79B | $1.75B | $1.64B | $1.62B | $1.61B | $1.62B | $1.59B | $1.64B | $1.61B | $1.70B | $1.69B | · | $1.72B | $1.74B | $1.63B | · | |
| Other Non-current Liabilities | $3.97B | $3.79B | $3.70B | $3.64B | $3.54B | $3.42B | $2.06B | $1.99B | $1.93B | $1.96B | $1.91B | · | $1.86B | $1.06B | $992M | · | |
| Long-term Debt | $11.72B | $12.39B | $7.92B | $7.66B | $8.24B | $7.86B | $8.15B | $4.39B | $4.73B | $5.25B | $4.78B | · | · | · | · | · | |
| Total Debt | $11.44B | $12.18B | $7.58B | · | $8.04B | $7.09B | $5.94B | · | $4.17B | $4.18B | $4.19B | · | $4.16B | $4.67B | $4.66B | · | |
| Common Stock | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | · | $3M | $3M | $3M | · | |
| Retained Earnings | $9.14B | $8.49B | $6.97B | $6.53B | $6.98B | $6.40B | $5.79B | $5.42B | $5.51B | $5.13B | $4.82B | · | $4.07B | $3.69B | $3.36B | · | |
| Treasury Stock | $11.45B | $10.44B | $10.43B | $10.33B | $10.33B | $10.33B | $10.28B | $9.82B | $9.30B | $8.75B | $8.69B | · | $7.97B | $7.87B | $7.86B | · | |
| AOCI | $-980M | $-961M | $-905M | $-901M | $-844M | $-1.20B | $-1.40B | $-989M | $-1.28B | $-1.26B | $-1.14B | · | $-1.23B | $-1.32B | $-1.41B | · | |
| Stockholders' Equity | $3.05B | $3.40B | $1.91B | $1.51B | $1.98B | $1.01B | $227M | $646M | $925M | $1.08B | $912M | · | $686M | $282M | $-178M | · | |
| Liabilities + Equity | $83.81B | $81.65B | $78.36B | $76.59B | $73.96B | $71.19B | $69.05B | $67.10B | $66.77B | $63.87B | $64.69B | · | $61.18B | $58.77B | $57.91B | · | |
| Shares Outstanding | 190,826,409 | 194,560,641 | 194,521,885 | 193,937,673 | 193,860,959 | 193,783,768 | 193,849,411 | 194,943,968 | 197,008,633 | 199,388,633 | 199,461,864 | · | 202,109,227 | 202,410,686 | 202,225,546 | · |
キャッシュフロー 17
| 指標 | トレンド | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $269M | $249M | $260M | $259M | $254M | $260M | $278M | · | · | · | · | · | · | · | · | · | |
| Stock-based Comp | $29M | $28M | $66M | $26M | $23M | $28M | $70M | $35M | $22M | $28M | $63M | $25M | $21M | $23M | $56M | $16M | |
| Deferred Tax | $55M | $178M | $14M | $55M | $-17M | $26M | $-5M | $4M | $-70M | $-40M | $3M | $-29M | $-28M | $-49M | $-12M | $139M | |
| Amort. of Intangibles | $119M | $117M | $126M | $127M | $126M | $138M | $166M | $167M | $165M | $166M | $166M | $171M | $170M | $141M | $72M | $73M | |
| Restructuring | $61M | $41M | $14M | $89M | $42M | $53M | $46M | $81M | $42M | $76M | $34M | $52M | $64M | $97M | $16M | $-146M | |
| Other Non-cash | · | · | $-3.21B | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Operating Cash Flow | $2.65B | $1.34B | $-2.31B | $3.13B | $109M | $3.35B | $-2.72B | $1.00B | $2.48B | $-878M | $885M | $1.83B | $745M | $630M | $710M | $1.16B | |
| CapEx | $226M | $166M | $119M | $250M | $183M | $129M | $106M | $182M | $118M | $113M | $74M | $175M | $104M | $103M | $76M | $174M | |
| Investing Cash Flow | $-240M | $-4.87B | $-299M | $-322M | $-235M | $-4.08B | $-343M | $-242M | $-144M | $-166M | $-66M | $-183M | $-819M | $-89M | $-1.51B | $-175M | |
| Debt Issued | · | · | · | · | · | · | · | · | $53M | $545M | $90M | · | $89M | $13M | $55M | · | |
| Net Debt Issued | · | · | $-132M | · | · | · | $-45M | · | · | · | $6M | · | · | · | $2M | · | |
| Stock Repurchased | · | · | · | $71.0K | $0 | $50M | $385M | $505M | $550M | $51M | $386M | $274M | $100M | $0 | $807M | $235M | |
| Net Stock Activity | · | · | · | · | · | · | $-385M | · | · | · | $-386M | · | · | · | $-807M | · | |
| Dividends Paid | $117M | $117M | $127M | $108M | $107M | $111M | $111M | $101M | $103M | $107M | $106M | $98M | $99M | $102M | $100M | $96M | |
| Financing Cash Flow | $-1.77B | $3.98B | $43M | $-684M | $215M | $-492M | $3.21B | $-957M | $-1.15B | $323M | $-552M | $-407M | $-82M | $-769M | $-964M | $-673M | |
| Net Change in Cash | $629M | $428M | $-2.59B | $2.12B | $97M | $-1.22B | $97M | $-179M | $1.19B | $-751M | $283M | $1.20B | $-140M | $-224M | $-1.68B | $291M | |
| Free Cash Flow | · | · | $-2.42B | · | · | · | $-2.82B | · | · | · | $811M | · | · | · | $634M | · |
収益性 8
| 指標 | トレンド | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 4.3% | 4.6% | 3.6% | · | 3.6% | 4.1% | 3.1% | · | 3.2% | 3.7% | 3.4% | · | 3.4% | 3.6% | 3.4% | · | |
| Operating Margin | 1.3% | 1.5% | 0.88% | · | 1.1% | 1.4% | 0.87% | · | 0.91% | 0.81% | 1.1% | · | 1.0% | 0.88% | 1.0% | · | |
| Net Margin | 0.90% | 2.1% | 0.65% | · | 0.85% | 0.95% | 0.60% | · | 0.65% | 0.62% | 0.83% | · | 0.72% | 0.69% | 0.76% | · | |
| Pretax Margin | 1.2% | 2.7% | 0.82% | · | 1.1% | 1.2% | 0.76% | · | 0.85% | 0.68% | 1.1% | · | 0.91% | 0.81% | 0.94% | · | |
| EBITDA Margin | 1.6% | 1.8% | 1.2% | · | 1.1% | 1.4% | 0.87% | · | 0.91% | 0.81% | 1.1% | · | 1.0% | 0.88% | 1.0% | · | |
| ROA | 0.97% | 2.1% | 0.76% | · | 0.98% | 1.1% | 0.73% | · | 0.76% | 0.69% | 0.98% | · | 0.81% | 0.75% | 0.83% | · | |
| ROE | 30.3% | 74.4% | 52.4% | · | 47.3% | 68.5% | 85.9% | · | 60.0% | 61.7% | 164.0% | · | 105.4% | 104.7% | 1513.0% | · | |
| ROIC | 6.0% | 5.7% | 6.4% | · | 6.7% | 9.9% | 9.1% | · | 10.2% | 9.5% | 12.4% | · | 10.9% | 9.5% | 11.3% | · |
流動性と支払能力 4
| 指標 | トレンド | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 0.9 | 0.9 | 0.9 | · | 0.9 | 0.9 | 0.9 | · | 0.9 | 0.9 | 0.9 | · | 0.9 | 0.9 | 0.9 | · | |
| Quick Ratio | 0.5 | 0.5 | 0.5 | · | 0.5 | 0.5 | 0.5 | · | 0.5 | 0.5 | 0.5 | · | 0.5 | 0.5 | 0.5 | · | |
| Debt / Equity | 3.8 | 3.6 | 4.0 | · | 4.1 | 7.0 | 26.2 | · | 4.5 | 3.9 | 4.6 | · | 6.1 | 16.6 | -26.1 | · | |
| LT Debt / Equity | 3.8 | 3.6 | 4.0 | · | 4.1 | 7.0 | 26.2 | · | 4.5 | 3.9 | 4.6 | · | 6.1 | 16.6 | -26.1 | · |
効率性 3
| 指標 | トレンド | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 1.1 | 1.0 | 1.2 | · | 1.1 | 1.1 | 1.2 | · | 1.2 | 1.1 | 1.2 | · | 1.1 | 1.1 | 1.1 | · | |
| Inventory Turnover | 3.9 | 3.8 | 3.7 | · | 4.0 | 4.0 | 4.0 | · | 4.1 | 3.8 | 3.9 | · | 4.0 | 3.8 | 3.7 | · | |
| Receivables Turnover | 3.4 | 3.2 | 3.4 | · | 3.3 | 3.3 | 3.5 | · | 3.3 | 3.2 | 3.6 | · | 3.4 | 3.4 | 3.5 | · |
バリュエーション（TTM） 14
| 指標 | トレンド | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $329.71B | $320.41B | $323.54B | · | $311.85B | $299.60B | $296.40B | · | $281.86B | $271.07B | $265.50B | · | $253.32B | $244.09B | $240.26B | · | |
| Net Income TTM | $3.65B | $3.61B | $2.45B | · | $2.38B | $2.11B | $1.99B | · | $1.99B | $1.94B | $2.00B | · | $1.80B | $1.87B | $1.88B | · | |
| Market Cap | $54.00B | $61.12B | $65.70B | · | $58.13B | $53.89B | $43.55B | · | $44.39B | $48.45B | $40.97B | · | $38.89B | $32.41B | $33.51B | · | |
| Enterprise Value | $62.63B | $71.13B | $71.53B | · | $63.94B | $59.00B | $46.27B | · | $45.25B | $50.56B | $42.28B | · | $41.66B | $35.54B | $36.47B | · | |
| P/E | 15.1 | 17.0 | 26.9 | · | 24.7 | 26.0 | 22.5 | · | 22.9 | 25.4 | 21.0 | · | 22.0 | 17.8 | 18.5 | · | |
| P/S | 0.2 | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.1 | · | 0.2 | 0.2 | 0.2 | · | 0.2 | 0.1 | 0.1 | · | |
| P/B | 17.7 | 18.0 | 34.4 | · | 29.4 | 53.2 | 192.2 | · | 48.0 | 44.7 | 44.9 | · | 56.7 | 115.0 | -188.1 | · | |
| P / Cash Flow | · | · | -28.5 | · | · | · | -16.0 | · | · | · | 46.3 | · | · | · | 47.2 | · | |
| P / FCF | · | · | -27.1 | · | · | · | -15.4 | · | · | · | 50.5 | · | · | · | 52.8 | · | |
| EV / EBITDA | 45.1 | 51.1 | 70.1 | · | 73.7 | 56.9 | 65.5 | · | 67.3 | 91.4 | 51.4 | · | 62.2 | 63.4 | 57.6 | · | |
| EV / FCF | · | · | -29.5 | · | · | · | -16.4 | · | · | · | 52.1 | · | · | · | 57.5 | · | |
| EV / Revenue | 0.2 | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.2 | · | 0.2 | 0.1 | 0.2 | · | |
| Earnings Yield | 6.6% | 5.9% | 3.7% | · | 4.0% | 3.8% | 4.5% | · | 4.4% | 3.9% | 4.8% | · | 4.5% | 5.6% | 5.4% | · | |
| Payout Ratio | · | · | 22.6% | · | · | · | 22.7% | · | · | · | 17.6% | · | · | · | 20.8% | · |
財務諸表 損益計算書、貸借対照表、キャッシュフロー — 年次、過去5年間
損益計算書
| 2025-09-30 | 2024-09-30 | 2023-09-30 | 2022-09-30 | 2021-09-30 | |
|---|---|---|---|---|---|
| 収益 | $321.33B | $293.96B | $262.17B | $238.59B | $213.99B |
| 粗利益率 % | 3.6% | 3.4% | 3.4% | 3.5% | 3.2% |
| 営業利益率 % | 0.82% | 0.74% | 0.89% | 0.99% | 1.1% |
| 純利益 | $1.55B | $1.51B | $1.75B | $1.70B | $1.54B |
| 希薄化後EPS | $7.96 | $7.53 | $8.53 | $8.04 | $7.39 |
貸借対照表
| 2025-09-30 | 2024-09-30 | 2023-09-30 | 2022-09-30 | 2021-09-30 | |
|---|---|---|---|---|---|
| 負債資本倍率 | 5.0 | 5.9 | 7.9 | -21.9 | 28.6 |
| 流動比率 | 0.9 | 0.9 | 0.9 | 0.9 | 0.9 |
| クイックレシオ | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 |
キャッシュフロー
| 2025-09-30 | 2024-09-30 | 2023-09-30 | 2022-09-30 | 2021-09-30 | |
|---|---|---|---|---|---|
| フリーキャッシュフロー | $3.21B | $3.00B | $3.45B | $2.21B | $2.23B |
最新ニュース この会社に言及した最近の見出し
マイ指標 あなた専用のウォッチリスト — 決算詳細から選択した行
あなたにとって重要なメトリクスを選択 — 上記の決算詳細の任意の行の横にある➕をクリックしてください。
選択内容は保存され、すべてのティッカーで引き継がれます。
機関投資家（13F） 1,493 提出者 · $31.4B合計 · 時点 2026年6月30日
四半期SECフォーム13Fでこの株式の保有を報告している機関。ロングポジションのみ。単一の提出者は、別々のオプションレッグで2回表示される場合があります。 大きな反対売買のプット/コール・レッグは、通常、マーケットメイクまたはヘッジされた在庫を反映しており、方向性への確信を示すものではありません。
| 新規ポジション | 解消済みポジション | 増加 | 減少 | 純株式数増減 |
|---|---|---|---|---|
| 102 (-56 前期比) | 172 (+41 前期比) | 434 (-101 前期比) | 595 (+65 前期比) | +8.4M |
Q1 2026と比較しました。 SECフォーム13Fの提出期限は四半期末から45日後ですが、遅延提出者向けの短いバッファーが含まれます。この期間内の四半期は、直近で完全に報告されたペアを優先するためスキップされます。
| 機関投資家 | 評価額 | 株式数 | % 追跡された13Fのうち | タイプ |
|---|---|---|---|---|
| VANGUARD CAPITAL MANAGEMENT LLC | $3,502,993,290 | 12,378,943 | 11.14% | 株式数 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $2,719,934,713 | 9,611,756 | 8.65% | 株式数 |
| STATE STREET CORP | $2,624,351,709 | 9,273,983 | 8.34% | 株式数 |
| Walgreens Boots Alliance, Inc. | $2,240,779,050 | 7,473,000 | 7.12% | 株式数 |
| GEODE CAPITAL MANAGEMENT, LLC | $1,358,112,555 | 4,819,419 | 4.32% | 株式数 |
| WELLINGTON MANAGEMENT GROUP LLP | $1,231,165,897 | 4,350,717 | 3.91% | 株式数 |
| FMR LLC | $850,228,724 | 3,004,554 | 2.70% | 株式数 |
| NORGES BANK | $700,042,999 | 2,473,825 | 2.23% | 株式数 |
| Capital Research Global Investors | $560,283,987 | 1,979,942 | 1.78% | 株式数 |
| Carmignac Gestion | $494,462,712 | 1,747,363 | 1.57% | 株式数 |
| Mitsubishi UFJ Asset Management Co., Ltd. | $483,772,138 | 1,709,563 | 1.54% | 株式数 |
| Mawer Investment Management Ltd. | $421,312,792 | 1,488,843 | 1.34% | 株式数 |
| DIMENSIONAL FUND ADVISORS LP | $410,282,013 | 1,449,862 | 1.30% | 株式数 |
| CITADEL ADVISORS LLC | $347,541,038 | 1,228,147 | 1.11% | 株式数 |
| AMERICAN CENTURY COMPANIES INC | $338,738,459 | 1,197,038 | 1.08% | 株式数 |
| NEUBERGER BERMAN GROUP LLC | $315,929,430 | 1,116,828 | 1.00% | 株式数 |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $313,668,332 | 1,108,447 | 1.00% | 株式数 |
| VANGUARD FIDUCIARY TRUST CO | $313,605,793 | 1,108,226 | 1.00% | 株式数 |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $294,327,781 | 1,040,101 | 0.94% | 株式数 |
| Sumitomo Mitsui Trust Group, Inc. | $293,610,144 | 1,037,565 | 0.93% | 株式数 |
| MILLENNIUM MANAGEMENT LLC | $268,966,547 | 950,479 | 0.86% | 株式数 |
| LAZARD ASSET MANAGEMENT LLC | $261,088,180 | 922,638 | 0.83% | 株式数 |
| Caisse de depot et placement du Quebec | $258,709,937 | 914,234 | 0.82% | 株式数 |
| Boston Partners | $231,295,970 | 817,358 | 0.74% | 株式数 |
| National Pension Service | $208,758,025 | 737,713 | 0.66% | 株式数 |
| GOLDMAN SACHS GROUP INC | $208,660,680 | 737,369 | 0.66% | 株式数 |
| ALLIANCEBERNSTEIN L.P. | $205,281,694 | 653,472 | 0.65% | 株式数 |
| NORDEA INVESTMENT MANAGEMENT AB | $180,668,066 | 644,564 | 0.57% | 株式数 |
| Burgundy Asset Management Ltd. | $174,893,972 | 599,753 | 0.56% | 株式数 |
| Balyasny Asset Management L.P. | $172,225,024 | 608,612 | 0.55% | 株式数 |
| Point72 Asset Management, L.P. | $171,131,023 | 604,746 | 0.54% | 株式数 |
| Assenagon Asset Management S.A. | $166,084,924 | 586,914 | 0.53% | 株式数 |
| Squarepoint Ops LLC | $154,024,599 | 544,295 | 0.49% | 株式数 |
| Swiss National Bank | $147,506,155 | 521,260 | 0.47% | 株式数 |
| BNP PARIBAS FINANCIAL MARKETS | $141,101,751 | 498,628 | 0.45% | 株式数 |
| Swedbank AB | $134,859,213 | 476,568 | 0.43% | 株式数 |
| TimesSquare Capital Management, LLC | $132,589,070 | 422,070 | 0.42% | 株式数 |
| Legal & General Group Plc | $129,674,734 | 458,247 | 0.41% | 株式数 |
| RHUMBLINE ADVISERS | $123,138,883 | 435,151 | 0.39% | 株式数 |
| Vanguard Global Advisers, LLC | $120,449,305 | 425,646 | 0.38% | 株式数 |
| BlackRock, Inc. | $119,463,969 | 422,164 | 0.38% | 株式数 |
| ENVESTNET ASSET MANAGEMENT INC | $117,740,633 | 416,074 | 0.37% | 株式数 |
| WESTFIELD CAPITAL MANAGEMENT CO LP | $113,208,499 | 400,058 | 0.36% | 株式数 |
| California Public Employees Retirement System | $110,655,367 | 391,036 | 0.35% | 株式数 |
| BANK OF AMERICA CORP /DE/ | $105,342,134 | 372,260 | 0.33% | 株式数 |
| SEB Asset Management AB | $104,030,095 | 367,624 | 0.33% | 株式数 |
| VANGUARD ASSET MANAGEMENT, Ltd | $101,511,435 | 358,723 | 0.32% | 株式数 |
| VANGUARD GROUP INC | $100,694,421 | 298,133 | 0.32% | 株式数 |
| Walleye Capital LLC | $98,419,595 | 347,797 | 0.31% | 株式数 |
| MIZUHO MARKETS AMERICAS LLC | $96,213,200 | 340,000 | 0.31% | 株式数 |
| JOHNSON INVESTMENT COUNSEL INC | $93,893,214 | 331,802 | 0.30% | 株式数 |
| STOREBRAND ASSET MANAGEMENT AS | $93,049,484 | 328,820 | 0.30% | 株式数 |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | $88,657,847 | 282,224 | 0.28% | 株式数 |
| Cornerstone Investment Partners, LLC | $86,260,510 | 304,829 | 0.27% | 株式数 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $85,771,238 | 303,100 | 0.27% | コールオプション |
| JONES FINANCIAL COMPANIES LLLP | $85,147,559 | 297,583 | 0.27% | 株式数 |
| CIBC Private Wealth Group LLC | $83,133,772 | 266,003 | 0.26% | 株式数 |
| Zurcher Kantonalbank (Zurich Cantonalbank) | $81,593,038 | 288,335 | 0.26% | 株式数 |
| FIL Ltd | $79,588,408 | 281,251 | 0.25% | 株式数 |
| LPL Financial LLC | $76,804,992 | 271,415 | 0.24% | 株式数 |
| TD Asset Management Inc | $76,770,210 | 271,292 | 0.24% | 株式数 |
| BANK OF MONTREAL /CAN/ | $70,057,359 | 247,570 | 0.22% | 株式数 |
| FORT WASHINGTON INVESTMENT ADVISORS INC /OH/ | $69,812,864 | 246,706 | 0.22% | 株式数 |
| PRINCIPAL FINANCIAL GROUP INC | $68,792,155 | 243,099 | 0.22% | 株式数 |
| CITADEL ADVISORS LLC | $68,622,650 | 242,500 | 0.22% | コールオプション |
| FIRST MANHATTAN CO. LLC. | $68,126,586 | 240,747 | 0.22% | 株式数 |
| AMERIPRISE FINANCIAL INC | $67,675,233 | 239,152 | 0.22% | 株式数 |
| TREMBLANT CAPITAL GROUP | $67,203,788 | 237,486 | 0.21% | 株式数 |
| RAYMOND JAMES FINANCIAL INC | $64,886,066 | 229,296 | 0.21% | 株式数 |
| EARNEST PARTNERS LLC | $63,127,461 | 223,081 | 0.20% | 株式数 |
| FERGUSON WELLMAN CAPITAL MANAGEMENT, INC | $60,624,220 | 214,235 | 0.19% | 株式数 |
| VICTORY CAPITAL MANAGEMENT INC | $60,395,855 | 213,428 | 0.19% | 株式数 |
| JENNISON ASSOCIATES LLC | $60,017,829 | 212,092 | 0.19% | 株式数 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | $59,924,694 | 211,763 | 0.19% | 株式数 |
| HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND | $57,032,921 | 201,544 | 0.18% | 株式数 |
| FJARDE AP-FONDEN /FOURTH SWEDISH NATIONAL PENSION FUND | $52,864,060 | 186,812 | 0.17% | 株式数 |
| BARCLAYS PLC | $51,304,557 | 181,301 | 0.16% | 株式数 |
| Mitsubishi UFJ Trust & Banking Corp | $51,082,984 | 180,518 | 0.16% | 株式数 |
| PFA Pension, Forsikringsaktieselskab | $50,217,651 | 177,460 | 0.16% | 株式数 |
| MARSHALL WACE, LLP | $50,044,447 | 176,848 | 0.16% | 株式数 |
| Susquehanna Portfolio Strategies, LLC | $49,878,621 | 176,262 | 0.16% | 株式数 |
| Sio Capital Management, LLC | $49,121,932 | 173,588 | 0.16% | 株式数 |
| WEALTH ENHANCEMENT ADVISORY SERVICES, LLC | $48,634,175 | 162,136 | 0.15% | 株式数 |
| Universal- Beteiligungs- und Servicegesellschaft mbH | $48,419,177 | 171,284 | 0.15% | 株式数 |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | $47,513,047 | 151,248 | 0.15% | 株式数 |
| AVIVA PLC | $47,242,096 | 166,945 | 0.15% | 株式数 |
| Jefferies Financial Group Inc. | $46,356,935 | 163,817 | 0.15% | 株式数 |
| Brandywine Global Investment Management, LLC | $45,181,831 | 133,773 | 0.14% | 株式数 |
| Asset Management One Co., Ltd. | $44,176,566 | 140,627 | 0.14% | 株式数 |
| Trajan Wealth LLC | $43,325,888 | 153,106 | 0.14% | 株式数 |
| STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM | $43,248,965 | 152,834 | 0.14% | 株式数 |
| Ensign Peak Advisors, Inc | $42,869,206 | 151,492 | 0.14% | 株式数 |
| CANADA PENSION PLAN INVESTMENT BOARD | $42,457,470 | 150,037 | 0.14% | 株式数 |
| UBS Group AG | $41,937,353 | 148,199 | 0.13% | 株式数 |
| Freestone Grove Partners LP | $41,195,379 | 145,577 | 0.13% | 株式数 |
| Qube Research & Technologies Ltd | $40,558,109 | 143,325 | 0.13% | 株式数 |
| VAN ECK ASSOCIATES CORP | $40,356,344 | 142,612 | 0.13% | 株式数 |
| MACKENZIE FINANCIAL CORP | $40,057,234 | 141,555 | 0.13% | 株式数 |
| DONALDSON CAPITAL MANAGEMENT, LLC | $38,839,791 | 137,253 | 0.12% | 株式数 |
| ROYAL BANK OF CANADA | $37,959,000 | 134,139 | 0.12% | 株式数 |
企業インサイダー 49 人のインサイダー · 23人の役員 · 27人の取締役
| インサイダー | 役職 | 最終アクティビティ | 保有株式数 | 12ヶ月購入 | 12ヶ月売却 | 12ヶ月純額 |
|---|---|---|---|---|---|---|
| Robert P. Mauch | President & CEO | 2025年6月18日 M | 44,094 | 0 | 0 | $0 |
| David R Yost | CEO | 2011年5月17日 M | 1,530,341 | 0 | 0 | $0 |
| Eva C Boratto | Chief Financial Officer | 2026年6月29日 A | — | 0 | 0 | $0 |
| Tim G. Guttman | Chief Financial Officer | 2018年11月9日 M | 53,505 | 0 | 0 | $0 |
| Michael D Dicandilo | Executive VP & CFO | 2011年5月2日 M | 89,698 | 0 | 0 | $0 |
| Kurt J Hilzinger | President & COO | 2007年2月15日 A | 176,400 | 0 | 0 | $0 |
| Elizabeth S Campbell | Executive Vice President | 2026年6月30日 A | 30,756 | 0 | 0 | $0 |
| Silvana Battaglia | Executive Vice President | 2026年6月30日 A | 23,624 | 0 | 0 | $0 |
| Steven H Collis | Executive Chairman | 2025年9月16日 M | 305,913 | 0 | 2 | $-13,314,729 |
| Lazarus Krikorian | SVP & Chief Accounting Officer | 2025年5月29日 S | 17,154 | 0 | 0 | $0 |
| Leslie E Donato | EVP & Chief Strategy Officer | 2024年6月28日 A | 9,525 | 0 | 0 | $0 |
| Gina Clark | Executive Vice President | 2024年5月31日 S | 13,284 | 0 | 0 | $0 |
| John G. Chou | Executive Vice President | 2021年12月20日 G | 81,367 | 0 | 0 | $0 |
| Kathy H. Gaddes | Executive Vice President | 2020年2月21日 M | 6,906 | 0 | 0 | $0 |
| Dale Danilewitz | Executive Vice President | 2019年5月23日 S | 1,085 | 0 | 0 | $0 |
| Howell Peyton R | Executive Vice President | 2018年4月4日 M | 47,989 | 0 | 0 | $0 |
| Sun Park | Executive Vice President | 2017年11月17日 F | 3,010 | 0 | 0 | $0 |
| James Frary | Executive Vice President | 2016年11月9日 A | 34,195 | 0 | 0 | $0 |
| Lawrence Marsh | Executive Vice President | 2016年4月29日 F | 8,897 | 0 | 0 | $0 |
| David W Neu | Executive Vice President | 2015年11月13日 F | 5,224 | 0 | 0 | $0 |
| June Barry | Executive Vice President | 2015年11月13日 M | 4,068 | 0 | 0 | $0 |
| Jeanne B. Fisher | Senior Vice President | 2010年2月1日 M | 27,190 | 0 | 0 | $0 |
| Terrance P Haas | Senior Vice President | 2008年2月27日 A | 25,728 | 0 | 0 | $0 |
| Lauren M Tyler | 取締役 | 2026年7月31日 A | 4,456 | 1 | 0 | $148,626 |
| Dennis M Nally | 取締役 | 2026年7月31日 A | 13,188 | 0 | 0 | $0 |
| Ellen Cooper | 取締役 | 2026年7月31日 A | 893 | 0 | 0 | $0 |
| Dermot Mark Durcan | 取締役 | 2026年6月18日 P | 31,767 | 2 | 0 | $2,161,800 |
| Lori Ryerkerk | 取締役 | 2025年7月1日 A | 516 | 0 | 0 | $0 |
| Werner Baumann | 取締役 | 2025年5月1日 A | 2,896 | 0 | 0 | $0 |
| Redonda Miller | 取締役 | 2025年3月6日 A | 3,194 | 0 | 0 | $0 |
| Frank Clyburn | 取締役 | 2025年3月6日 A | 1,157 | 0 | 0 | $0 |
| Lorence H. Kim | 取締役 | 2025年3月6日 A | 3,524 | 0 | 0 | $0 |
| Richard W Gochnauer | 取締役 | 2024年3月11日 M | 28,762 | 0 | 0 | $0 |
| Kathleen W Hyle | 取締役 | 2024年3月11日 M | 24,406 | 0 | 0 | $0 |
| Henry Wadsworth Mcgee III | 取締役 | 2023年3月9日 A | 20,479 | 0 | 0 | $0 |
| Jane E Henney MD | 取締役 | 2023年3月5日 M | 24,685 | 0 | 0 | $0 |
| Michael J Long | 取締役 | 2023年3月5日 M | 17,724 | 0 | 0 | $0 |
| Douglas R Conant | 取締役 | 2019年3月4日 M | 8,062 | 0 | 0 | $0 |
| Richard C Gozon | 取締役 | 2016年2月29日 M | 51,484 | 0 | 0 | $0 |
| Edward E Hagenlocker | 取締役 | 2015年3月2日 M | 3,351 | 0 | 0 | $0 |
| Charles H Cotros | 取締役 | 2012年12月7日 M | 26,773 | 0 | 0 | $0 |
| Lawrence J Wilson | 取締役 | 2009年5月1日 A | 35,942 | 0 | 0 | $0 |
| Rodney H Brady | 取締役 | 2007年2月19日 A | 52,746 | 0 | 0 | $0 |
| James R Mellor | 取締役 | 2006年1月3日 M | 32,246 | 0 | 0 | $0 |
| Robert E Martini | 取締役 | 2004年1月23日 G | 1,602,739 | 0 | 0 | $0 |
| Francis G Rodgers | 取締役 | 2003年11月3日 A | 7,918 | 0 | 0 | $0 |
| AMERISOURCEBERGEN CORP | 10%オーナー | 2007年7月31日 J | 0 | 0 | 0 | $0 |
| James F Cleary | — | 2026年3月11日 M | 160,357 | 0 | 0 | $0 |
| Lon R Greenberg | — | 2026年3月5日 A | 18,408 | 0 | 0 | $0 |
SECフォーム3/4/5提出書類からのインサイダー；純額＝公開市場のP/Sのみ
アクティビストおよび5%超のオーナー 3保有
SECスケジュール13Dを提出した投資家 — 発行体の影響を与える意図（アクティビストの保有、取締役会キャンペーン、M&A）を持つ5%超の受益権所有。各行は、その提出者のポジションの最新の既知の状態を示します。
| 提出者 | 提出済み | 保有 | ステータス | 目的 | 提出書類 |
|---|---|---|---|---|---|
| Walgreens Boots Alliance Holdings LLC, WBA Investments, Inc., Walgreens Boots Alliance, Inc. ×21 提出書類 | 2025年6月9日 | 4.96% | 修正 | — | SEC |
| AB Acquisitions Holdings Limited, Alliance Santé Participations S.A., NEWCIP S.A., Stefano Pessina, KKR Sprint (2006) Limited, KKR 2006 Fund (Overseas), Limited Partnership, KKR Associates 2006 (Overseas), Limited Partnership, KKR 2006 Limited, KKR Sprint (European II) Limited, KKR European Fund II, Limited Partnership, KKR Associates Europe II, Limited Partnership, KKR Europe II Limited, KKR Sprint (KPE) Limited, KKR PEI Investments, L.P., KKR PEI Associates, L.P., KKR PEI GP Limited, KKR Fund Holdings L.P., KKR Fund Holdings GP Limited, KKR Group Holdings L.P., KKR Group Limited, KKR & Co. L.P., KKR Management LLC, Henry R. Kravis, George R. Roberts | 2015年1月23日 | — | 初回提出 | — | SEC |
| WAB Holdings LLC, Walgreens Pharmacy Strategies, LLC, Bond Drug Company of Illinois, LLC, Walgreen Eastern Co., Inc., Walgreen Arizona Drug Co., Walgreen Hastings Co., Walgreen International Investments LLC, WBA Investments, LLC, Walgreen Co., Alliance Boots Luxembourg S.à r.l., Alliance Boots Holdings Limited, AB Acquisitions UK Holdco 7 Limited, AB Acquisitions Limited, Alliance Boots International Limited, Alliance Boots Limited, AB Acquisitions UK Topco Limited, AB Acquisitions Luxco 1 S.à r.l., Alliance Boots GmbH, Walgreen Swiss International GmbH, Ontario Holdings WBA Limited, Walgreen International S.à r.l., Superior Bermuda GP, Superior Luxco 3 S.à r.l., Walgreens Boots Alliance Scottish LP, WBA 1 Scottish LLP, Superior Luxco 2 S.à r.l., Superior Luxco 1 S.à r.l., Walgreen Investments Luxembourg SCS, Walgreen Investments Co, Walgreens Boots Alliance, Inc. ×2 提出書類 | 2015年1月16日 | — | 初回提出 | 取締役会キャンペーン | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
ETF保有状況 212のETFが保有
ウェイトは直接株式保有（N-PORT）のみを反映しています。レバレッジ型またはデリバティブベースのファンドは、表示されていない追加のスワップエクスポージャーを保有している可能性があります。
| ファンド | ウェイト | 単位 | 時点 | ソース |
|---|---|---|---|---|
| JMID · Janus Detroit Street Trust | 3.11% | 1,841 NS | 2026年4月30日 | N-PORT |
| IYK · iShares Trust | 2.76% | 121,004 SH | 2026年8月8日 | 日次 |
| FXG · First Trust Exchange-Traded AlphaDE… | 2.40% | 19,060 NS | 2026年4月30日 | N-PORT |
| PAWZ · ProShares Trust | 2.36% | 2,847 NS | 2026年5月31日 | N-PORT |
| GDOC · Goldman Sachs ETF Trust | 2.34% | 1,750 NS | 2026年5月31日 | N-PORT |
| POWA · Invesco Exchange-Traded Self-Indexe… | 2.26% | 12,908 SH | 2026年8月8日 | 日次 |
| MEDI · Harbor ETF Trust | 2.16% | 1,935 NS | 2026年4月30日 | N-PORT |
| FGSI · First Trust Exchange-Traded Fund IV | 1.91% | 186 NS | 2026年4月30日 | N-PORT |
| RWL · Invesco Exchange-Traded Fund Trust … | 1.83% | 568,607 SH | 2026年8月8日 | 日次 |
| SWP · Manager Directed Portfolios | 1.75% | 10,059 NS | 2026年5月31日 | N-PORT |
| IWP · iShares Trust | 1.73% | 1,079,322 SH | 2026年8月8日 | 日次 |
| RSPH · Invesco Exchange-Traded Fund Trust | 1.72% | 42,128 SH | 2026年8月8日 | 日次 |
| QIDX · Spinnaker ETF Series | 1.66% | 2,065 NS | 2026年4月30日 | N-PORT |
| EPMB · Harbor ETF Trust | 1.56% | 228 NS | 2026年4月30日 | N-PORT |
| USMV · iShares Trust | 1.29% | 958,985 SH | 2026年8月8日 | 日次 |
| ESMV · iShares Trust | 1.27% | 308 SH | 2026年8月8日 | 日次 |
| UPSD · ETF Series Solutions | 1.21% | 3,966 NS | 2026年4月30日 | N-PORT |
| SRHQ · Elevation Series Trust | 1.17% | 7,354 NS | 2026年4月30日 | N-PORT |
| AMOM · Exchange Listed Funds Trust | 1.17% | 1,161 NS | 2026年4月30日 | N-PORT |
| ACWV · iShares, Inc. | 1.17% | 120,628 SH | 2026年8月8日 | 日次 |
| FMAG · FIDELITY COVINGTON TRUST | 1.10% | 9,066 NS | 2026年4月30日 | N-PORT |
| NULV · Nushares ETF Trust | 1.10% | 73,945 NS | 2026年4月30日 | N-PORT |
| COWZ · Pacer Funds Trust | 1.03% | 608,442 NS | 2026年4月30日 | N-PORT |
| QQWZ · Pacer Funds Trust | 1.02% | 1,555 NS | 2026年4月30日 | N-PORT |
| GROZ · Zacks Trust | 0.93% | 3,136 NS | 2026年5月31日 | N-PORT |
| FHLC · FIDELITY COVINGTON TRUST | 0.92% | 84,961 NS | 2026年4月30日 | N-PORT |
| VOE · VANGUARD INDEX FUNDS | 0.90% | 1,187,313 SH | 2026年8月8日 | 日次 |
| CURE · Direxion Shares ETF Trust | 0.86% | 3,879 NS | 2026年4月30日 | N-PORT |
| RPV · Invesco Exchange-Traded Fund Trust | 0.85% | 45,117 SH | 2026年8月8日 | 日次 |
| IMCG · iShares Trust | 0.84% | 105,034 SH | 2026年8月8日 | 日次 |
| IXJ · iShares Trust | 0.80% | 102,068 SH | 2026年8月8日 | 日次 |
| ALTL · Pacer Funds Trust | 0.79% | 2,471 NS | 2026年4月30日 | N-PORT |
| JOET · Virtus ETF Trust II | 0.79% | 6,030 NS | 2026年4月30日 | N-PORT |
| VHT · VANGUARD WORLD FUND | 0.77% | 555,571 SH | 2026年8月8日 | 日次 |
| PALC · Pacer Funds Trust | 0.76% | 5,696 NS | 2026年4月30日 | N-PORT |
| RXL · ProShares Trust | 0.76% | 2,029 NS | 2026年5月31日 | N-PORT |
| AVIE · AMERICAN CENTURY ETF TRUST | 0.75% | 285 NS | 2026年5月31日 | N-PORT |
| ROE · EA Series Trust | 0.73% | 7,012 NS | 2026年5月29日 | N-PORT |
| TAX · EA Series Trust | 0.72% | 680 NS | 2026年5月29日 | N-PORT |
| LSEQ · Harbor ETF Trust | 0.68% | 342 NS | 2026年4月30日 | N-PORT |
| DUHP · Dimensional ETF Trust | 0.68% | 249,048 NS | 2026年4月30日 | N-PORT |
| SPVU · Invesco Exchange-Traded Fund Trust … | 0.66% | 3,314 NS | 2026年5月31日 | N-PORT |
| IUS · Invesco Exchange-Traded Self-Indexe… | 0.63% | 18,623 SH | 2026年8月8日 | 日次 |
| VO · VANGUARD INDEX FUNDS | 0.50% | 4,005,623 SH | 2026年8月8日 | 日次 |
| QARP · DBX ETF Trust | 0.49% | 1,374 NS | 2026年5月29日 | N-PORT |
| FLCC · Federated Hermes ETF Trust | 0.47% | 2,120 NS | 2026年5月31日 | N-PORT |
| RECS · Columbia ETF Trust I | 0.44% | 77,004 NS | 2026年4月30日 | N-PORT |
| IWR · iShares Trust | 0.43% | 760,297 SH | 2026年8月8日 | 日次 |
| IMCB · iShares Trust | 0.43% | 22,227 SH | 2026年8月8日 | 日次 |
| JSTC · Tidal Trust I | 0.40% | 4,993 NS | 2026年5月31日 | N-PORT |